BioCentury | Nov 17, 2017
Company News

CRISPR, Casebia get rights to CureVac editing constructs

...immunosuppressive activity than unmodified Tregs (see BioCentury Innovations, Nov. 2 ). In September, Casebia and Seattle Children's Research Institute...
...Basel, Switzerland Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Gene/Cell therapy Elizabeth S. Eaton Bayer AG CRISPR Therapeutics AG CureVac AG Seattle Children's Research Institute Casebia...
BioCentury | Nov 13, 2017
Company News

CRISPR, Casebia get rights to CureVac editing constructs

...immunosuppressive activity than unmodified Tregs (see BioCentury Innovations, Nov. 2) . In September, Casebia and Seattle Children's Research Institute...
...and prevent autoimmune diseases (see BioCentury Extra, Sept. 27) . Elizabeth S. Eaton Bayer AG CRISPR Therapeutics AG CureVac AG Seattle Children's Research Institute CRISPR-associated...
BioCentury | Nov 2, 2017
Emerging Company Profile

Tougher Tregs

...Cas9 - CRISPR-associated protein 9 TCR - T cell receptor Mark Zipkin, Staff Writer Bayer AG CRISPR Therapeutics AG Seattle Children's Research Institute TRACT...
BioCentury | Oct 6, 2017
Company News

ABX grants Endocyte exclusive, worldwide rights to PSMA-targeting ligand

...comprises a fluorescein isothiocyanate (FITC) molecule and a tumor-specific folate ligand. Under a partnership with Seattle Children's Research Institute...
BioCentury | Oct 2, 2017
Company News

Endocyte soars on deal for ABX's CRPC candidate

...comprises a fluorescein isothiocyanate (FITC) molecule and a tumor-specific folate ligand. Under a partnership with Seattle Children's Research Institute...
BioCentury | Sep 29, 2017
Company News

Casebia, Seattle Children's partner to develop gene-edited Tregs

...Casebia Therapeutics (Cambridge, Mass.) and Seattle Children's Research Institute (Seattle, Wash.) partnered to develop CRISPR- Cas9 (CRISPR-associated protein 9)-edited...
...Oct. 13, 2016 ). CRISPR Therapeutics AG (NASDAQ:CRSP), Basel, Switzerland Bayer AG (Xetra:BAYN), Leverkusen, Germany Seattle Children's Research Institute...
...Seattle, Wash. Business: Gene/Cell therapy, Autoimmune Mary Romeo Bayer AG Caladrius Biosciences Inc. Celgene Corp. CRISPR Therapeutics AG Delinia Inc. Iltoo Pharma Seattle Children's Research Institute TxCell...
BioCentury | Sep 27, 2017
Company News

Casebia, Seattle Children's partner to develop gene-edited Tregs

...Casebia Therapeutics (Cambridge, Mass.) and Seattle Children's Research Institute (Seattle, Wash.) partnered to develop CRISPR- Cas9 (CRISPR-associated protein 9)-edited...
...year (see BioCentury Innovations, Oct. 13, 2016) . Mary Romeo Bayer AG Caladrius Biosciences Inc. Celgene Corp. CRISPR Therapeutics AG Iltoo Pharma Seattle Children's Research Institute TxCell...
BioCentury | Jun 8, 2017
Finance

The bio-tech bridge

...Fibrosis Foundation Harvard University Memorial Sloan Kettering Cancer Center Multiple Myeloma Research Foundation (MMRF) National Institutes of Health Prexton Therapeutics S.A. Seattle Children's Research Institute Stanford...
BioCentury | Mar 17, 2017
Company News

Endocyte, Seattle Children’s Research Institute deal

...Endocyte said it will fund the research, which will take place at the institute. Alicia Parker Endocyte Inc. Seattle Children's Research Institute CAR...
BioCentury | Dec 10, 2015
Distillery Therapeutics

Therapeutics: Aurora kinase A (AURKA; Aurora-A)

...et al. Sci. Transl. Med.; published online Nov. 25, 2015 doi:10.1126/scitranslmed.aad3231 CONTACT: Leslie S. Kean, Seattle Children's Research Institute...
Items per page:
1 - 10 of 30
BioCentury | Nov 17, 2017
Company News

CRISPR, Casebia get rights to CureVac editing constructs

...immunosuppressive activity than unmodified Tregs (see BioCentury Innovations, Nov. 2 ). In September, Casebia and Seattle Children's Research Institute...
...Basel, Switzerland Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Gene/Cell therapy Elizabeth S. Eaton Bayer AG CRISPR Therapeutics AG CureVac AG Seattle Children's Research Institute Casebia...
BioCentury | Nov 13, 2017
Company News

CRISPR, Casebia get rights to CureVac editing constructs

...immunosuppressive activity than unmodified Tregs (see BioCentury Innovations, Nov. 2) . In September, Casebia and Seattle Children's Research Institute...
...and prevent autoimmune diseases (see BioCentury Extra, Sept. 27) . Elizabeth S. Eaton Bayer AG CRISPR Therapeutics AG CureVac AG Seattle Children's Research Institute CRISPR-associated...
BioCentury | Nov 2, 2017
Emerging Company Profile

Tougher Tregs

...Cas9 - CRISPR-associated protein 9 TCR - T cell receptor Mark Zipkin, Staff Writer Bayer AG CRISPR Therapeutics AG Seattle Children's Research Institute TRACT...
BioCentury | Oct 6, 2017
Company News

ABX grants Endocyte exclusive, worldwide rights to PSMA-targeting ligand

...comprises a fluorescein isothiocyanate (FITC) molecule and a tumor-specific folate ligand. Under a partnership with Seattle Children's Research Institute...
BioCentury | Oct 2, 2017
Company News

Endocyte soars on deal for ABX's CRPC candidate

...comprises a fluorescein isothiocyanate (FITC) molecule and a tumor-specific folate ligand. Under a partnership with Seattle Children's Research Institute...
BioCentury | Sep 29, 2017
Company News

Casebia, Seattle Children's partner to develop gene-edited Tregs

...Casebia Therapeutics (Cambridge, Mass.) and Seattle Children's Research Institute (Seattle, Wash.) partnered to develop CRISPR- Cas9 (CRISPR-associated protein 9)-edited...
...Oct. 13, 2016 ). CRISPR Therapeutics AG (NASDAQ:CRSP), Basel, Switzerland Bayer AG (Xetra:BAYN), Leverkusen, Germany Seattle Children's Research Institute...
...Seattle, Wash. Business: Gene/Cell therapy, Autoimmune Mary Romeo Bayer AG Caladrius Biosciences Inc. Celgene Corp. CRISPR Therapeutics AG Delinia Inc. Iltoo Pharma Seattle Children's Research Institute TxCell...
BioCentury | Sep 27, 2017
Company News

Casebia, Seattle Children's partner to develop gene-edited Tregs

...Casebia Therapeutics (Cambridge, Mass.) and Seattle Children's Research Institute (Seattle, Wash.) partnered to develop CRISPR- Cas9 (CRISPR-associated protein 9)-edited...
...year (see BioCentury Innovations, Oct. 13, 2016) . Mary Romeo Bayer AG Caladrius Biosciences Inc. Celgene Corp. CRISPR Therapeutics AG Iltoo Pharma Seattle Children's Research Institute TxCell...
BioCentury | Jun 8, 2017
Finance

The bio-tech bridge

...Fibrosis Foundation Harvard University Memorial Sloan Kettering Cancer Center Multiple Myeloma Research Foundation (MMRF) National Institutes of Health Prexton Therapeutics S.A. Seattle Children's Research Institute Stanford...
BioCentury | Mar 17, 2017
Company News

Endocyte, Seattle Children’s Research Institute deal

...Endocyte said it will fund the research, which will take place at the institute. Alicia Parker Endocyte Inc. Seattle Children's Research Institute CAR...
BioCentury | Dec 10, 2015
Distillery Therapeutics

Therapeutics: Aurora kinase A (AURKA; Aurora-A)

...et al. Sci. Transl. Med.; published online Nov. 25, 2015 doi:10.1126/scitranslmed.aad3231 CONTACT: Leslie S. Kean, Seattle Children's Research Institute...
Items per page:
1 - 10 of 30